Crystal Lake, Illinois-based Aptar Pharma ($ATR) launched technology designed to monitor dosing and adherence in its inhalers. It also teamed up with Adapt Pharma to ...
U.S. regulators on Friday approved the first high-dose nasal spray for reversing opioid overdoses. The Food and Drug Administration approved Hikma Pharmaceuticals’ Kloxxado, a spray containing 8 ...
New York — A new, higher-dose nasal spray for reversing opioid overdoses did not save more lives than the previous standard dose, but it did cause more vomiting and other side effects, researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback